⌘K

Home/Filings/3/0001013762-23-002838

3//SEC Filing

Eureka Therapeutics, Inc. 3

Accession 0001013762-23-002838

CIK 0001844417other

View on SEC.gov Company Profile

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 4:15 PM ET

Size

14.0 KB

Accession

0001013762-23-002838

Insider Transaction Report

Form 3

Period: 2023-09-29

Estrella Immunopharma, Inc.ESLA

Eureka Therapeutics, Inc.

10% Owner

Holdings

Common Stock
25,277,831

Documents

2 files

Issuer

Estrella Immunopharma, Inc.

CIK 0001844417

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001386560

Filing Metadata

Form type: 3
Filed: Oct 9, 8:00 PM ET
Accepted: Oct 10, 4:15 PM ET
Size: 14.0 KB

View on SEC.gov